• Contact us
  • Suomeksi

Search
  • HOME
  • INVESTORS
    • Investors
    • Why invest?
    • Reports and presentations
    • Corporate Governance
      • Articles of Association
      • General Meetings
      • Board of Directors
      • Management
      • Auditor
    • Releases
    • Investor relations
  • TECHNOLOGY
    • Technology
    • Traumatic brain injury
    • Biomarker R&D program
      • Proof of concept
      • Second clinical trial
      • Third clinical trial
      • Assay development plan
      • Drug development program
    • IP rights
  • COMPANY PROFILE
    • Company Profile
    • Letter from CEO
    • Business Strategy
    • Board of Directors
    • Management
    • Team
    • Scientific and Clinical Advisory Board
    • Partners
  • NEWS & EVENTS
    • News & events
    • Company releases
    • Yhtiötiedotteet
    • Press Releases
    • Lehdistötiedotteet
    • Articles
    • Videos
  • CONTACT US

Search

  • News & events
  • Company releases
  • Yhtiötiedotteet
  • Press Releases
  • Lehdistötiedotteet
  • Articles
  • Videos

Medicortexin lehdistötiedotteet

Medicortex Finland Oy

Pharma City
Itäinen Pitkäkatu 4 B, 4th floor
FI-20520 Turku, Finland
Tel. +358 (0)400 488817
adrian.harel@medicortex.fi
  • Contact us
  • Suomeksi

Search
  • INVESTORS
  • Why invest?
  • Reports and presentations
  • Corporate Governance
  • Releases
  • Investor relations
  • TECHNOLOGY
  • Traumatic brain injury
  • Biomarker R&D program
  • IP rights
  • COMPANY PROFILE
  • Letter from CEO
  • Business Strategy
  • Board of Directors
  • Management
  • Team
  • Scientific and Clinical Advisory Board
  • Partners
  • NEWS & EVENTS
  • Company releases
  • Yhtiötiedotteet
  • Press Releases
  • Lehdistötiedotteet
  • Articles
  • Videos
  • CONTACT US
VERKKOVARAANI